APOLIPOPROTEIN A1
apo A1


Back

CLINICAL SIGNIFICANCE
High concentrations of apolipoprotein A1 in serum are observed in familial a-lipoprotinemia and reduction of bodyweight.

Low concentrations of Apo-A1 deficiency are observed in the following cases: A-â-lipoproteinemia, lipoproteinic lipase factor deficiency (Apo C-II), cases of a-hypolipoproteinemia, various forms of hypertriglyceridemia, uncontrolled diabetes, early coronary disease, hepatocellular disorders, cholestasis, holestasis, nephrotic syndrome, chronic renal failure, smoking, diet high in carbohydrates or polyunsaturated fats.
CHARACTERISTICS

Form: Liquid ready-to-use
Shelf life: 24 months @ 2-8 C
On-Board Stability: 30 days
Sample: Serum or plasma with EDTA
Detection limit: 1 mg/dL
Linearity: 12-220 mg/dL


Packaging
For Use On
MEDILYZER
EX-OLYMPUS
GENERAL PURPOSE
SIEMENS ADVIA
Packaging
6x30 Tests & 6x100 Tests
4x50 Tests & 4x100 Tests
R1 3x100, R2 75
4x80 Tests & 4x200 Tests